Renal Handling of Lithium

Jonathan M. Meyer; Stephen M. Stahl

doi:10.1017/9781009225069.005

2 - Renal Handling of Lithium

Proximal and Distal Handling of Lithium; The Staging of Chronic Kidney Disease; Lithium Related Effects on Renal Function

Published online by Cambridge University Press: 09 February 2024

Jonathan M. Meyer and

Stephen M. Stahl

Show author details

Jonathan M. Meyer: Affiliation:
University of California, San Diego
Stephen M. Stahl: Affiliation:
University of California, San Diego

Book contents

Get access

Summary

In a 1989 review entitled “Long-term treatment with lithium and renal function: A review and reappraisal,” the pioneering Danish psychopharmacologist Mogens Schou concluded: “The fear of eventual kidney insufficiency as a result of long-term lithium treatment can be set at rest” [1]. Despite the certainty advanced by the preeminent authority on lithium at that time – the man responsible for all of the early data on lithium’s efficacy and the first double-blind placebo-controlled trials – fear of lithium’s long-term renal adverse effects remains a significant concern to clinicians, a concern that is often disproportionate to the emerging data in this area.

Information

Type: Chapter
Information: The Lithium Handbook
Stahl's Handbooks
, pp. 95 - 150

DOI: https://doi.org/10.1017/9781009225069.005 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Subscription

Individual access

Subscriptions are only available for individuals and not institutional access. Subscribe now

References

Schou, M. (1989). [Long-term treatment with lithium and renal function: A review and reappraisal. Encephale, 15, 437–442.Google Scholar PubMed

Aiff, H., Attman, P.-O., Aurell, M., et al. (2014). The impact of modern treatment principles may have eliminated lithium-induced renal failure. J Psychopharmacol, 28, 151–154.10.1177/0269881113516202CrossRef Google Scholar PubMed

Kirkham, E., Skinner, J., Anderson, T., et al. (2014). One lithium level > 1.0 mmol/L causes an acute decline in eGFR: Findings from a retrospective analysis of a monitoring database. BMJ Open, 4, e006020.10.1136/bmjopen-2014-006020CrossRef Google Scholar

Castro, V. M., Roberson, A. M., McCoy, T. H., et al. (2016). Stratifying risk for renal insufficiency among lithium-treated patients: An electronic health record study. Neuropsychopharmacol, 41, 1138–1143.10.1038/npp.2015.254CrossRef Google Scholar PubMed

Kessing, L. V., Gerds, T. A., Feldt-Rasmussen, B., et al. (2015). Use of lithium and anticonvulsants and the rate of chronic kidney disease: A nationwide population-based study. JAMA Psychiatry, 72, 1182–1191.10.1001/jamapsychiatry.2015.1834CrossRef Google Scholar PubMed

Clos, S., Rauchhaus, P., Severn, A., et al. (2015). Long-term effect of lithium maintenance therapy on estimated glomerular filtration rate in patients with affective disorders: A population-based cohort study. Lancet Psychiatry, 2, 1075–1083.10.1016/S2215-0366(15)00316-8CrossRef Google Scholar

Dastych, M., Synek, O. and Gottwaldova, J. (2019). Impact of long-term lithium treatment on renal function in patients with bipolar disorder based on novel biomarkers. J Clin Psychopharmacol, 39, 238–242.10.1097/JCP.0000000000001030CrossRef Google Scholar PubMed

Bisogni, V., Rossitto, G., Reghin, F., et al. (2016). Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders. J Hypertens, 34, 20–28.10.1097/HJH.0000000000000758CrossRef Google Scholar PubMed

Alsady, M., Baumgarten, R., Deen, P. M., et al. (2016). Lithium in the kidney: Friend and foe? J Am Soc Nephrol, 27, 1587–1595.10.1681/ASN.2015080907CrossRef Google Scholar PubMed

Schoot, T. S., Molmans, T. H. J., Grootens, K. P., et al. (2020). Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy. Eur Neuropsychopharmacol, 31, 16–32.10.1016/j.euroneuro.2019.11.006CrossRef Google Scholar PubMed

Łukawska, E., Frankiewicz, D., Izak, M., et al. (2021). Lithium toxicity and the kidney with special focus on nephrotic syndrome associated with the acute kidney injury: A case-based systematic analysis. J Appl Toxicol, 41, 1896–1909.10.1002/jat.4167CrossRef Google Scholar PubMed

Kortenoeven, M. L., Li, Y., Shaw, S., et al. (2009). Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int, 76, 44–53.10.1038/ki.2009.91CrossRef Google Scholar PubMed

Kalita-De Croft, P., Bedford, J. J., Leader, J. P., et al. (2018). Amiloride modifies the progression of lithium-induced renal interstitial fibrosis. Nephrology (Carlton), 23, 20–30.10.1111/nep.12929CrossRef Google Scholar PubMed

Vallée, C., Howlin, B. and Lewis, R. (2021). Ion selectivity in the ENaC/DEG family: A systematic review with supporting analysis. Int J Mol Sci, 22. doi: 10.3390/ijms222010998.CrossRef Google Scholar

Vandenbeuch, A. and Kinnamon, S. C. (2020). Is the amiloride-sensitive Na+ channel in taste cells really ENaC? Chem Senses, 45, 233–234.10.1093/chemse/bjaa011CrossRef Google Scholar

Davis, J., Desmond, M. and Berk, M. (2018). Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal. Nephrology (Carlton), 23, 897–903.10.1111/nep.13263CrossRef Google Scholar PubMed

Bedford, J. J., Weggery, S., Ellis, G., et al. (2008). Lithium-induced nephrogenic diabetes insipidus: Renal effects of amiloride. Clin J Am Soc Nephrol, 3, 1324–1331.10.2215/CJN.01640408CrossRef Google Scholar PubMed

Macau, R. A., da Silva, T. N., Silva, J. R., et al. (2018). Use of acetazolamide in lithium-induced nephrogenic diabetes insipidus: A case report. Endocrinol Diabetes Metab Case Rep, doi: 10.1530/EDM-17-0154.CrossRef Google Scholar

Chen, T. K., Knicely, D. H. and Grams, M. E. (2019). Chronic kidney disease diagnosis and management: A review. JAMA, 322, 1294–1304.10.1001/jama.2019.14745CrossRef Google Scholar PubMed

Inker, L. A., Eneanya, N. D., Coresh, J., et al. (2021). New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med, 385, 1737–1749.10.1056/NEJMoa2102953CrossRef Google Scholar PubMed

Öhlund, L., Ott, M., Oja, S., et al. (2018). Reasons for lithium discontinuation in men and women with bipolar disorder: A retrospective cohort study. BMC Psychiatry, 18, 37–46.10.1186/s12888-018-1622-1CrossRef Google Scholar PubMed

Kinahan, J. C., NiChorcorain, A., Cunningham, S., et al. (2015). Diagnostic accuracy of tests for polyuria in lithium-treated patients. J Clin Psychopharmacol, 35, 434–441.10.1097/JCP.0000000000000350CrossRef Google Scholar PubMed

Kinahan, J. C., Ni Chorcorain, A., Cunningham, S., et al. (2022). Managing polyuria during lithium treatment: A preliminary prospective observational study. Ir J Psychol Med, 39, 20–27.10.1017/ipm.2019.9CrossRef Google Scholar PubMed

Koomans, H. A., Boer, W. H. and Dorhout Mees, E. J. (1989). Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int, 36, 2–12.10.1038/ki.1989.153CrossRef Google Scholar PubMed

Thomsen, K. and Shirley, D. G. (2006). A hypothesis linking sodium and lithium reabsorption in the distal nephron. Nephrol Dial Transplant, 21, 869–880.10.1093/ndt/gfk029CrossRef Google Scholar PubMed

Jackson, E. K. (2018). Drugs affecting renal excretory function. In Brunton, L. L., Hilal-Dandan, R. and Knollmann, B. C., eds., Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 13th Edition. Chicago: McGraw-Hill, pp. 445–470.Google Scholar

Meyer, J. M. (2022). Pharmacotherapy of psychosis and mania. In Brunton, L. L. and Knollmann, B. C., eds., Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 14th Edition. Chicago: McGraw-Hill, pp.357–384.Google Scholar

Giebisch, G., Windhager, E. H. and Aronson, P. S. (2017). Glomerular filtration and renal blood flow. In Boron, W. F. and Boulpaep, E. L., eds., Medical Physiology: A Cellular and Molecular Approach, 3rd Edition. Philadelphia, PA: Elsevier, pp. 739–753.Google Scholar

Atherton, J. C., Doyle, A., Gee, A., et al. (1991). Lithium clearance: Modification by the loop of Henle in man. J Physiol, 437, 377–391.10.1113/jphysiol.1991.sp018601CrossRef Google Scholar PubMed

Fransen, R., Boer, W. H., Boer, P., et al. (1993). Effects of furosemide or acetazolamide infusion on renal handling of lithium: A micropuncture study in rats. Am J Physiol, 264, R129–134.Google Scholar PubMed

Gimenez, I. (2006). Molecular mechanisms and regulation of furosemide-sensitive Na-K-Cl cotransporters. Curr Opin Nephrol Hypertens, 15, 517–523.10.1097/01.mnh.0000242178.44576.b0CrossRef Google Scholar PubMed

Levey, A. S., Grams, M. E. and Inker, L. A. (2022). Uses of GFR and albuminuria level in acute and chronic kidney disease. N Engl J Med, 386, 2120–2128.10.1056/NEJMra2201153CrossRef Google Scholar PubMed

De Vriese, A. S., Sethi, S., Nath, K. A., et al. (2018). Differentiating primary, genetic, and secondary FSGS in adults: A clinicopathologic approach. J Am Soc Nephrol, 29, 759–774.10.1681/ASN.2017090958CrossRef Google Scholar PubMed

Nyengaard, J. R., Bendtsen, T. F., Christensen, S., et al. (1994). The number and size of glomeruli in long-term lithium-induced nephropathy in rats. Apmis, 102, 59–66.10.1111/j.1699-0463.1994.tb04846.xCrossRef Google Scholar PubMed

Min, G., Christensen, S., Marcussen, N., et al. (2000). Glomerular structure in lithium-induced chronic renal failure in rats. Apmis, 108, 652–662.10.1034/j.1600-0463.2000.d01-12.xCrossRef Google Scholar PubMed

de Groot, T., Doty, R., Damen, L., et al. (2021). Genetic background determines renal response to chronic lithium treatment in female mice. Physiol Genomics, 53, 406–415.10.1152/physiolgenomics.00149.2020CrossRef Google Scholar PubMed

Markowitz, G. S., Radhakrishnan, J., Kambham, N., et al. (2000). Lithium nephrotoxicity: A progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol, 11, 1439–1448.10.1681/ASN.V1181439CrossRef Google Scholar PubMed

Walker, R. J., Leader, J. P., Bedford, J. J., et al. (2013). Chronic interstitial fibrosis in the rat kidney induced by long-term (6-mo) exposure to lithium. Am J Physiol Renal Physiol, 304, F300–307.10.1152/ajprenal.00182.2012CrossRef Google Scholar PubMed

Grünfeld, J.-P. and Rossier, B. C. (2009). Lithium nephrotoxicity revisited. Nat Rev Nephrol, 5, 270–276.10.1038/nrneph.2009.43CrossRef Google Scholar PubMed

Kwon, T. H., Laursen, U. H., Marples, D., et al. (2000). Altered expression of renal AQPs and Na(+) transporters in rats with lithium-induced NDI. Am J Physiol Renal Physiol, 279, F552–564.10.1152/ajprenal.2000.279.3.F552CrossRef Google Scholar PubMed

Pradhan, B. K., Chakrabarti, S., Irpati, A. S., et al. (2011). Distress due to lithium-induced polyuria: Exploratory study. Psychiatry Clin Neurosci, 65, 386–388.10.1111/j.1440-1819.2011.02214.xCrossRef Google Scholar PubMed

Rej, S., Segal, M., Low, N. C., et al. (2014). The McGill Geriatric Lithium-Induced Diabetes Insipidus Clinical Study (McGLIDICS). Can J Psychiatry, 59, 327–334.10.1177/070674371405900606CrossRef Google Scholar PubMed

Schou, M., Amdisen, A., Thomsen, K., et al. (1982). Lithium treatment regimen and renal water handling: The significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmacology, 77, 387–390.10.1007/BF00432777CrossRef Google Scholar PubMed

Meyer, J. M. and Nasrallah, H. A., eds. (2009). Medical Illness and Schizophrenia, 2nd Edition. Washington, DC: American Psychiatric Press, Inc.Google Scholar PubMed

McElroy, S. L. and Keck, P. E., Jr. (2014). Metabolic syndrome in bipolar disorder: A review with a focus on bipolar depression. J Clin Psychiatry, 75, 46–61.10.4088/JCP.13r08634CrossRef Google Scholar PubMed

Hayes, J. F., Marston, L., Walters, K., et al. (2017). Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000–2014. Br J Psychiatry, 211, 175–181.10.1192/bjp.bp.117.202606CrossRef Google Scholar PubMed

Lurie, I., Shoval, G., Hoshen, M., et al. (2021). The association of medical resource utilization with physical morbidity and premature mortality among patients with schizophrenia: An historical prospective population cohort study. Schizophr Res, 237, 62–68.10.1016/j.schres.2021.08.019CrossRef Google Scholar PubMed

Lepkifker, E., Sverdlik, A., Iancu, I., et al. (2004). Renal insufficiency in long-term lithium treatment. J Clin Psychiatry, 63, 850–856.10.4088/JCP.v65n0618CrossRef Google Scholar

Tondo, L., Abramowicz, M., Alda, M., et al. (2017). Long-term lithium treatment in bipolar disorder: Effects on glomerular filtration rate and other metabolic parameters. Int J Bipolar Disord, 5, 27.10.1186/s40345-017-0096-2CrossRef Google Scholar PubMed

Presne, C., Fakhouri, F., Noel, L. H., et al. (2003). Lithium-induced nephropathy: Rate of progression and prognostic factors. Kidney Int, 64, 585–592.10.1046/j.1523-1755.2003.00096.xCrossRef Google Scholar PubMed

Aiff, H., Attman, P.-O., Aurell, M., et al. (2015). Effects of 10 to 30 years of lithium treatment on kidney function. J Psychopharmacol, 29, 608–614.10.1177/0269881115573808CrossRef Google Scholar PubMed

Golic, M., Aiff, H., Attman, P. O., et al. (2018). Compliance with the safety guidelines for long-term lithium treatment in Sweden. J Psychopharmacol, 32, 1104–1109.10.1177/0269881118780014CrossRef Google Scholar PubMed

Werneke, U., Ott, M., Renberg, E. S., et al. (2012). A decision analysis of long-term lithium treatment and the risk of renal failure. Acta Psychiatr Scand, 126, 186–197.10.1111/j.1600-0447.2012.01847.xCrossRef Google Scholar PubMed

Wingård, L., Brandt, L., Bodén, R., et al. (2019). Monotherapy vs. combination therapy for post mania maintenance treatment: A population based cohort study. Eur Neuropsychopharmacol, 29, 691–700.10.1016/j.euroneuro.2019.04.003CrossRef Google Scholar PubMed

Tuazon, J., Casalino, D., Syed, E., et al. (2008). Lithium-associated kidney microcysts. Scientific World Journal, 8, 828–829.10.1100/tsw.2008.112CrossRef Google Scholar PubMed

Slaughter, A., Pandey, T. and Jambhekar, K. (2010). MRI findings in chronic lithium nephropathy: A case report. J Radiol Case Rep, 4, 15–21.Google Scholar PubMed

Jon´czyk-Potoczna, K., Abramowicz, M., Chłopocka-Woz´niak, M., et al. (2016). Renal sonography in bipolar patients on long-term lithium treatment. J Clin Ultrasound, 44, 354–359.10.1002/jcu.22336CrossRef Google Scholar PubMed

Tabibzadeh, N., Faucon, A. L., Vidal-Petiot, E., et al. (2021). Determinants of kidney function and accuracy of kidney microcysts detection in patients treated with lithium salts for bipolar disorder. Front Pharmacol, 12, 1–12.Google Scholar PubMed

Golshayan, D., Nseir, G., Venetz, J. P., et al. (2012). MR imaging as a specific diagnostic tool for bilateral microcysts in chronic lithium nephropathy. Kidney Int, 81, 601.10.1038/ki.2011.449CrossRef Google Scholar PubMed

Farshchian, N., Farnia, V., Aghaiani, M. R., et al. (2013). MRI findings and renal function in patients on lithium therapy. Curr Drug Saf, 8, 257–260.10.2174/15748863113089990047CrossRef Google Scholar PubMed

Davis, J., Desmond, M. and Berk, M. (2018). Lithium and nephrotoxicity: A literature review of approaches to clinical management and risk stratification. BMC Nephrol, 19, 305.10.1186/s12882-018-1101-4CrossRef Google Scholar PubMed

Gahr, M., Wezel, F., Bolenz, C., et al. (2019). Lithium therapy associated with renal and upper and lower urinary tract tumors: Results from a retrospective single-center analysis. J Clin Psychopharmacol, 39, 530–532.10.1097/JCP.0000000000001098CrossRef Google Scholar PubMed

Rookmaaker, M. B., van Gerven, H. A., Goldschmeding, R., et al. (2012). Solid renal tumours of collecting duct origin in patients on chronic lithium therapy. Clin Kidney J, 5, 412–415.10.1093/ckj/sfs091CrossRef Google Scholar PubMed

Zaidan, M., Stucker, F., Stengel, B., et al. (2014). Increased risk of solid renal tumors in lithium-treated patients. Kidney Int, 86, 184–190.10.1038/ki.2014.2CrossRef Google Scholar PubMed

Cohen, Y., Chetrit, A., Cohen, Y., et al. (1998). Cancer morbidity in psychiatric patients: Influence of lithium carbonate treatment. Med Oncol, 15, 32–36.10.1007/BF02787342CrossRef Google Scholar PubMed

Licht, R. W., Grabenhenrich, L. B., Nielsen, R. E., et al. (2014). Lithium and renal tumors: A critical comment to the report by Zaidan et al. Kidney Int, 86, 857.10.1038/ki.2014.178CrossRef Google Scholar

Kessing, L. V., Gerds, T. A., Feldt-Rasmussen, B., et al. (2015). Lithium and renal and upper urinary tract tumors – results from a nationwide population-based study. Bipolar Disord, 17, 805–813.10.1111/bdi.12344CrossRef Google Scholar PubMed

Pottegård, A., Hallas, J., Jensen, B. L., et al. (2016). Long-term lithium use and risk of renal and upper urinary tract cancers. J Am Soc Nephrol, 27, 249–255.10.1681/ASN.2015010061CrossRef Google Scholar PubMed

Martinsson, L., Westman, J., Hallgren, J., et al. (2016). Lithium treatment and cancer incidence in bipolar disorder. Bipolar Disord, 18, 33–40.10.1111/bdi.12361CrossRef Google Scholar PubMed

Huang, R. Y., Hsieh, K. P., Huang, W. W., et al. (2016). Use of lithium and cancer risk in patients with bipolar disorder: Population-based cohort study. Br J Psychiatry, 209, 393–399.10.1192/bjp.bp.116.181362CrossRef Google Scholar PubMed

Anmella, G., Fico, G., Lotfaliany, M., et al. (2021). Risk of cancer in bipolar disorder and the potential role of lithium: International collaborative systematic review and meta-analyses. Neurosci Biobehav Rev, 126, 529–541.10.1016/j.neubiorev.2021.03.034CrossRef Google Scholar PubMed

Plenge, P., Mellerup, E. T., Bolwig, T. G., et al. (1982). Lithium treatment: Does the kidney prefer one daily dose instead of two? Acta Psychiatr Scand, 66, 121–128.10.1111/j.1600-0447.1982.tb00920.xCrossRef Google Scholar PubMed

Carter, L., Zolezzi, M. and Lewczyk, A. (2013). An updated review of the optimal lithium dosage regimen for renal protection. Can J Psychiatry, 58, 595–600.10.1177/070674371305801009CrossRef Google Scholar PubMed

Amdisen, A. (1977). Serum level monitoring and clinical pharmacokinetics of lithium. Clin Pharmacokinet, 2, 73–92.10.2165/00003088-197702020-00001CrossRef Google Scholar PubMed

Greil, W. (1981). [Pharmacokinetics and toxicology of lithium]. Bibl Psychiatr, 161, 69–103.Google Scholar

Swartz, C. M. (1987). Correction of lithium levels for dose and blood sampling times. J Clin Psychiatry, 48, 60–64.Google Scholar PubMed

Kusalic, M. and Engelsmann, F. (1996). Renal reactions to changes of lithium dosage. Neuropsychobiology, 34, 113–116.Google Scholar PubMed

Nolen, W. A., Licht, R. W., Young, A. H., et al. (2019). What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disord, 21, 394–409.10.1111/bdi.12805CrossRef Google Scholar

Shaddock, R., Anderson, K. V. and Beyth, R. (2020). Renal repercussions of medications. Prim Care, 47, 691–702.10.1016/j.pop.2020.08.006CrossRef Google Scholar PubMed

Ruffenach, S. J., Siskind, M. S. and Lien, Y. H. (1992). Acute interstitial nephritis due to omeprazole. Am J Med, 93, 472–473.10.1016/0002-9343(92)90181-ACrossRef Google Scholar PubMed

Wei, X., Yu, J., Xu, Z., et al. (2022). Incidence, pathogenesis, and management of proton pump inhibitor-induced nephrotoxicity. Drug Saf, 45, 703–712.10.1007/s40264-022-01181-4CrossRef Google Scholar PubMed

Lazarus, B., Chen, Y., Wilson, F. P., et al. (2016). Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med, 176, 238–246.10.1001/jamainternmed.2015.7193CrossRef Google Scholar PubMed

Al-Aly, Z., Maddukuri, G. and Xie, Y. (2020). Proton pump inhibitors and the kidney: Implications of current evidence for clinical practice and when and how to deprescribe. Am J Kidney Dis, 75, 497–507.10.1053/j.ajkd.2019.07.012CrossRef Google Scholar PubMed

Attridge, R. L., Frei, C. R., Ryan, L., et al. (2013). Fenofibrate-associated nephrotoxicity: A review of current evidence. Am J Health Syst Pharm, 70, 1219–1225.10.2146/ajhp120131CrossRef Google Scholar PubMed

Zingerman, B., Ziv, D., Feder Krengel, N., et al. (2020). Cessation of bezafibrate in patients with chronic kidney disease improves renal function. Sci Rep, 10, 19768.10.1038/s41598-020-76861-1CrossRef Google Scholar PubMed

Dohmen, K., Onohara, S. Y. and Harada, S. (2021). Effects of switching from fenofibrate to pemafibrate for asymptomatic primary biliary cholangitis. Korean J Gastroenterol, 78, 227–234.10.4166/kjg.2021.092CrossRef Google Scholar PubMed

Zhang, J., Ji, X., Dong, Z., et al. (2021). Impact of fenofibrate therapy on serum uric acid concentrations: A review and meta-analysis. Endocr J, 68, 829–837.10.1507/endocrj.EJ20-0808CrossRef Google Scholar

Broeders, N., Knoop, C., Antoine, M., et al. (2000). Fibrate-induced increase in blood urea and creatinine: Is gemfibrozil the only innocuous agent? Nephrol Dial Transplant, 15, 1993–1999.10.1093/ndt/15.12.1993CrossRef Google Scholar PubMed

Gray, M. P., Barreto, E. F., Schreier, D. J., et al. (2022). Consensus obtained for the nephrotoxic potential of 167 drugs in adult critically ill patients using a modified Delphi method. Drug Saf, 45, 389–398.10.1007/s40264-022-01173-4CrossRef Google Scholar PubMed

Morriss, R. and Benjamin, B. (2008). Lithium and eGFR: A new routinely available tool for the prevention of chronic kidney disease. Br J Psychiatry, 193, 93–95.10.1192/bjp.bp.108.051268CrossRef Google Scholar PubMed

Cockcroft, D. W. and Gault, M. H. (1976). Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31–41.Google Scholar PubMed

Inker, L. A. and Titan, S. (2021). Measurement and estimation of GFR for use in clinical practice: Core curriculum 2021. Am J Kidney Dis, 78, 736–749.10.1053/j.ajkd.2021.04.016CrossRef Google Scholar PubMed

Meyer, J. M. and Stahl, S. M. (2021). The Clinical Use of Antipsychotic Plasma Levels (Stahl’s Handbooks). New York: Cambridge University Press.10.1017/9781009002103CrossRef Google Scholar

Shannon, J. A. and Smith, H. W. (1935). The excretion of inulin, xylose and urea by normal and phlorizinized man. J Clin Invest, 14, 393–401.10.1172/JCI100690CrossRef Google Scholar PubMed

Eneanya, N. D., Yang, W. and Reese, P. P. (2019). Reconsidering the consequences of using race to estimate kidney function. JAMA, 322, 113–114.10.1001/jama.2019.5774CrossRef Google Scholar PubMed

Diao, J. A., Wu, G. J., Taylor, H. A., et al. (2021). Clinical implications of removing race from estimates of kidney function. JAMA, 325, 184–186.10.1001/jama.2021.3461CrossRef Google Scholar PubMed

Powe, N. R. (2020). Black kidney function matters: Use or misuse of race? JAMA, 324, 737–738.10.1001/jama.2020.13378CrossRef Google Scholar PubMed

Delgado, C., Baweja, M., Crews, D. C., et al. (2021). A unifying approach for GFR estimation: Recommendations of the NKF–ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. Am J Kidney Dis, 79, 268–288.e261.10.1053/j.ajkd.2021.08.003CrossRef Google Scholar PubMed

Diao, J. A., Inker, L. A., Levey, A. S., et al. (2021). In search of a better equation – performance and equity in estimates of kidney function. N Engl J Med, 384, 396–399.10.1056/NEJMp2028243CrossRef Google Scholar PubMed

Shlipak, M. G., Inker, L. A. and Coresh, J. (2022). Serum cystatin C for estimation of GFR. JAMA, 328, 883–884.10.1001/jama.2022.12407CrossRef Google Scholar PubMed

Tummalapalli, S. L., Shlipak, M. G., Damster, S., et al. (2020). Availability and affordability of kidney health laboratory tests around the globe. Am J Nephrol, 51, 959–965.10.1159/000511848CrossRef Google Scholar PubMed

Stookey, J. D. (2019). Analysis of 2009–2012 Nutrition Health and Examination Survey (NHANES) data to estimate the median water intake associated with meeting hydration criteria for individuals aged 12–80 in the US population. Nutrients, 11, 657–700.10.3390/nu11030657CrossRef Google Scholar PubMed

Sureda-Vives, M., Morell-Garcia, D., Rubio-Alaejos, A., et al. (2017). Stability of serum, plasma and urine osmolality in different storage conditions: Relevance of temperature and centrifugation. Clin Biochem, 50, 772–776.10.1016/j.clinbiochem.2017.03.019CrossRef Google Scholar PubMed

Meyer, J. M. and Stahl, S. M. (2019). The Clozapine Handbook (Stahl’s Handbooks).Cambridge: Cambridge University Press.10.1017/9781108553575CrossRef Google Scholar

Goldman, M. B. (2010). The assessment and treatment of water imbalance in patients with psychosis. Clin Schizophr Relat Psychoses, 4, 115–123.10.3371/CSRP.4.2.3CrossRef Google Scholar PubMed

Nederlof, M., Heerdink, E. R., Egberts, A. C. G., et al. (2018). Monitoring of patients treated with lithium for bipolar disorder: An international survey. Int J Bipolar Disord, 6, 12–20.10.1186/s40345-018-0120-1CrossRef Google Scholar PubMed

Accessibility standard: WCAG 2.1 AA

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

The HTML of this chapter complies with version 2.1 of the Web Content Accessibility Guidelines (WCAG), covering newer accessibility requirements and improved user experiences and achieves the intermediate (AA) level of WCAG compliance, covering a wider range of accessibility requirements.

Content Navigation

Table of contents navigation
Allows you to navigate directly to chapters, sections, or non‐text items through a linked table of contents, reducing the need for extensive scrolling.

Index navigation
Provides an interactive index, letting you go straight to where a term or subject appears in the text without manual searching.

Reading Order & Textual Equivalents

Single logical reading order
You will encounter all content (including footnotes, captions, etc.) in a clear, sequential flow, making it easier to follow with assistive tools like screen readers.

Visual Accessibility

Use of colour is not sole means of conveying information
You will still understand key ideas or prompts without relying solely on colour, which is especially helpful if you have colour vision deficiencies.

Structural and Technical Features

ARIA roles provided
You gain clarity from ARIA (Accessible Rich Internet Applications) roles and attributes, as they help assistive technologies interpret how each part of the content functions.